On Demand
Newer Veterinary Oncology Drugs: Tanovea, Laverdia, Stelfonta and More
Hosted by VetFolio
Dates TBD Online / Virtual
About This Event
This self-paced course reviews recent advancements in veterinary cancer therapy and diagnostics. Dr. Douglas H. Thamm covers new treatment options including Tigilanol tiglate for mast cell tumors, immune checkpoint inhibitors, Verdinexor for lymphoma, and Rabacfosadine for canine lymphoma, enhancing cancer treatment outcomes for dogs.
Sign in to unlock everything networkED.global adds to this event
We enrich every event with details scattered across the web — organized, verified, in one place:
- Earning CE? CE credits, accreditation, and which licenses it counts toward — tracked automatically.
- Speaking? Call-for-proposal deadlines and submission details.
- Exhibiting or sponsoring? Exhibit and sponsorship opportunities.
- Hosting events? Be connected directly to your target audiences.
Plus full agenda, pricing, registration, contacts, and topics covered.